This study was performed to investigate the effect of fuel combustion enhancing apparatus(FCEA) for ionization of intaking air into cylinder combustion chamber on the combustion performance and emissions characteristics in a 4-cylinder common-rail direct injection diesel engine. The experiments were applied to the engine at an engine speed of 1,500rpm under 20Nm, 40Nm, 60Nm and 80Nm conditions. The test results were compared to each other with or without the FCEA. In the case of the FCEA, the combustion pressure, peak combustion pressure and rate of heat release were increased slightly and the brake specific fuel consumption(BSFC) was decreased slightly when compared to that without the FCEA under all loads at an engine speed of 1,500rpm. However, in the case of the FCEA, the nitrogen oxide(NOx) were increased slightly, the carbon monoxide(CO) and particulate matter(PM) were decreased slightly when compared to that without the FCEA under all loads at an engine speed of 1,500rpm.

Voltage dependent calcium channel (VDCC), one of the most important regulator of Ca 2+ concentration in neuron, play an essential role in the central processing of nociceptive information. The present study investigated the antinociceptive effects of L, T or N type VDCC blockers on the formalin-induced orofacial inflammatory pain. Experiments were carried out on adult male Sprague-Dawley rats weighing 220-280 g. Anesthetized rats were individually fixed on a stereotaxic frame and a polyethylene (PE) tube was implanted for intracisternal injection. After 72 hours, 5% formalin (50 μL) was applied subcutaneously to the vibrissa pad and nociceptive scratching behavior was recorded for nine successive 5 min intervals. VDCC blockers were administered intracisternally 20 minutes prior to subcutaneous injection of formalin into the orofacial area. The intracisternal administration of 350 or 700 μg of verapamil, a blocker of L type VDCC, significantly decreased the number of scratches and duration in the behavioral responses produced by formalin injection. Intracisternal administration of 75 or 150 μg of mibefradil, a T type VDCC blocker, or 11 or 22 μg of cilnidipine, a N type VDCC blocker, also produced significant suppression of the number of scratches and duration of scratching in the first and second phase. Neither intracisternal administration of all VDCC blockers nor vehicle did not affect in motor dysfunction. The present results suggest that central VDCCs play an important role in orofacial nociceptive transmission and a targeted inhibition of the VDCCs is a potentially important treatment approach for inflammatory pain originating in the orofacial area.

The present study was performed to determine the ability of canine oocytes to achieve nuclear maturation according to oocyte diameter and different culture environments. All of the collected oocytes were classified by grade 1 to 3 and by their diameters such as <100㎛, <100㎛ to <110㎛, <110㎛ to <120㎛, >120㎛. Oocytes were cultured in culture medium supplemented with 10%FBS, 0.4%BSA,10% porcine follicular fluid (pFF), 10% canine serum (CS), or 10% canine estrus serum (CES). The mean number of oocytes recovered from estrus status ovaries was significantly higher than that of anestrus status ovaries (p<0.01). The maturation rate of grade 1 oocytes (>120㎛) was significantly higher than that of the other groups (p<0.05). Nuclear maturation to MI to MII in diameter of >110㎛ groups was significantly higher than that in <100㎛ group (p<0.05). The oocytes cultured in 10% FBS­supplemented group were significantly higher rate of GVBD compared to the other supplemented groups (p<0.05), and oocytes maturation to MI to MII in 10% FBS-, 0.4% BSA-, and 10% pFF-supplemented groups were significantly higher than those in 10% CS-supplemented group (p<0.05). Based on these results, the estrus status and the size of oocyte affect positively to improve nuclear maturation of canine immature oocytes in vitro. Among several protein sources, porcine follicular fluid was the most effective supplementation to culture medium to achieve higher in vitro maturation rate.